A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.

Saved in:
Bibliographic Details
Title: A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma.
Authors: Burge ME; Cancer Research UK Clinical Centre, University of Leeds, Cookridge Hospital, Leeds, UK., Smith D, Topham C, Jackson DP, Anthoney DA, Halstead F, Seymour MT
Source: British journal of cancer [Br J Cancer] 2006 May 08; Vol. 94 (9), pp. 1281-6.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Print ISSN: 0007-0920 (Print) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0007-0920
DOI:10.1038/sj.bjc.6603084